Dossier · BIRK · Dormant
BIRK · Birkenstock Holding plc · Stock research
Last analysed ·
Against its published line
The red mark is the published kill line. The dot is where the name closed on the last session. Distance is drawn on a square-root scale, so the first two points of cushion take half the track and a name sitting on its line is legible; past 8% a name reads simply as well clear. A trigger written on weekly closes is graded on weekly closes, so a name trading through such a line mid-week reads as pending, not hit.
Current thesis
The August frame's $36 weekly level broke — the week ending 2026-08-21 closed $35.64, retracing the entire 2026-08-13 beat-and-raise reaction ($41.01 premarket, then a −4.02% close at $39.35 on 2026-08-14). Fundamentals still guide to 15% cc growth and ≥€710M adjusted EBITDA, but the price narrative is dead and no company catalyst exists before the ~December FY2026 print.
Kill line
A weekly close below $31 loses the May 2026 low of $31.12 and turns the FY26 range into a distribution top; secondary condition — the $52.05 median target cluster following Williams Trading's 2026-08-19 cut to $39 down toward spot, with no Q4/FY26 results date announced by fiscal year end 2026-09-30.
Pick status
Open commitment scored if the kill line above fires How this is scored →Latest analysis and events for BIRK —
As of 23 August 2026, the latest FrontierPicks analysis for Birkenstock Holding plc (BIRK): The August frame's $36 weekly level broke — the week ending 2026-08-21 closed $35.64, retracing the entire 2026-08-13 beat-and-raise reaction ($41.01 premarket, then a −4.02% close at $39.35 on 2026-08-14). Fundamentals still guide to 15% cc growth and ≥€710M adjusted EBITDA, but the price narrative is dead and no company catalyst exists before the ~December FY2026 print.
Kill line: A weekly close below $31 loses the May 2026 low of $31.12 and turns the FY26 range into a distribution top; secondary condition — the $52.05 median target cluster following Williams Trading's 2026-08-19 cut to $39 down toward spot, with no Q4/FY26 results date announced by fiscal year end 2026-09-30.
Current Thesis
The prior note named $36 as the weekly close that would hand back the entire reaction to the 2026-08-13 print. The week ending Friday 2026-08-21 closed $35.64. That condition is met, and the June-to-August recovery frame is now broken on price as well as on flow: the $41.01 premarket print of 2026-08-13 (+11.6%) is fully retraced, the shares sit 33.3% under the $53.40 52-week high, and RSI(14) at 41.5 is nowhere near washed out. The operating business did not break — Q3 FY2026 revenue was €720M, +15% constant currency, and management raised the FY26 guide to 15% cc growth with adjusted EBITDA of at least €710M. What broke is the market's willingness to pay for it. From here the name is a valuation-and-patience proposition with no company-dated event until the FY2026 print, which the prior year's cadence puts around mid-December.
The narrative is dead. Dated by the 2026-08-14 session — a beat-and-raise that closed −4.02% at $39.35 — and confirmed by the 2026-08-21 weekly close at $35.64 through the level the July and August frames both leaned on. The narrative an investor was buying in June (a buyback-funded V back toward $53.40) has failed as a price story. A revival would need the tape to take back the print range, not another guidance raise.
Bullish and bearish views on Birkenstock Holding plc
The model's bull view on Birkenstock Holding plc (BIRK), in brief: Q3 FY2026 (quarter ended June 30, reported 2026-08-13): revenue €720M, +13% reported and +15% constant currency, DTC +16% cc — the fastest DTC pace in two years and ahead of wholesale for the first time in that span. The bear view: Six sessions after the raise, the whole move is gone. Both cases follow in full.
Bull Case
- Q3 FY2026 (quarter ended June 30, reported 2026-08-13): revenue €720M, +13% reported and +15% constant currency, DTC +16% cc — the fastest DTC pace in two years and ahead of wholesale for the first time in that span.
- FY2026 guidance raised 2026-08-13 to 15% cc revenue growth (top end of the prior 13–15%), adjusted EBITDA of at least €710M from at least €700M, and adjusted EBITDA margin 30.2–30.5%. S&P had modelled 28.5–29.0% for 2026 in June; the company guided the floor of its own range up and away from that.
- Adjusted EPS €0.74, +19% year-on-year, on weighted average shares of 181.4M versus 186.5M — the May $250M accelerated repurchase is showing up in the per-share line.
- Q3 adjusted EBITDA €242M, +11%, margin 33.7%, down only 70bps against a 130bps adjusted gross-margin hit to 59.2%.
- Sponsorship remains far above spot: 22 analysts, average target $54.55 and median $52.05 as of 2026-08-23 (stockanalysis.com), with Guggenheim reiterating $60 on 2026-08-14, Telsey at $50 and William Blair reiterating Buy on 2026-08-18.
- Third-party screens put the forward P/E at 14.75 on 2026-08-14 against a 15% cc growth guide.
Bear Case
- Six sessions after the raise, the whole move is gone. The path from $41.01 premarket (2026-08-13) to a $39.35 close (2026-08-14) to a $35.64 weekly close (2026-08-21) is a continuous distribution sequence with no reclaim attempt inside it.
- The first target cut of the cycle landed on 2026-08-19: Williams Trading (Sam Poser) reiterated Hold and took the target to $39 from $44. Nothing has been raised since William Blair's 2026-08-18 reiteration.
- Lower highs unbroken since June: $48.75 (June), $45.99 (2026-07-02), $44.36 (2026-07-17), then the $43 shelf lost in early August ahead of the print.
- The USD-converted EPS line missed again — adjusted $0.86 versus $0.87 consensus (Benzinga, 2026-08-13) — even with a shrinking share count doing arithmetic work.
- Tariff drag is a run-rate item: roughly 70bps of the 130bps adjusted gross-margin decline came from US tariffs, about 60bps from currency, the rest mix.
- Leverage rose by design — net leverage 1.8x LTM adjusted EBITDA from 1.5x, which management said would have been 1.4x excluding repurchases, guided to 1.6–1.7x at year-end — against S&P's BB+ with a negative outlook from June 2026.
- Governance churn: Alexandre Arnault resigned from the board on 2026-08-06, citing professional commitments.
Setup & Price Structure
Last completed daily close 2026-08-21: $35.64, 33.3% below the $53.40 52-week high, with a three-month price change of −13.9% and RSI(14) at 41.5. There is no base — the decline from $48.75 has produced no multi-week range, no higher low, and the one high-volume up-day of the quarter (2026-08-13) was sold the following session.
Below spot the next structural reference is the May 2026 low at $31.12; between here and there the chart is empty. Overhead sits a stack of failed levels: $39.35 (2026-08-14 close), $41.01 (print premarket), and the $43 shelf that gave way before the results.
Positioning observables, stated as observables: the median sell-side target of $52.05 across 22 analysts sits roughly 46% above the 2026-08-21 close, so the analyst distribution is uniformly above the market with only downside revision left available; the one action since the print was a cut. Benzinga's consumer-discretionary "whale activity" screens flagged the name on 2026-08-14, which places it in retail-facing unusual-activity coverage rather than in quiet accumulation. The repurchase authority of up to $500M is the only mechanical bid in the float, and it is funded by the 19 June 2026 €900M 4.500% notes due 2033, so every share retired adds leverage. There is no earnings date inside the next 30 days, which removes any forced repricing event and leaves drift as the default.
Catalyst Calendar (next 30 days)
- 2026-09-30 — FY2026 fiscal year end (38 days out, just outside the window). The raised guide — 15% cc revenue growth, adjusted EBITDA ≥€710M, margin 30.2–30.5% — stops being a forecast on this date.
- ~2026-11-18 (est.) — press release announcing the Q4/FY2026 results date. The equivalent FY2025 announcement was issued 2025-11-18; this is the first company communication that can appear on the tape.
- Nothing else is dated. Any move between now and late November is flow, sell-side revision or sector beta.
Elapsed catalysts
- ~2026-12 (est.) — Q4 and full fiscal year 2026 results. Not announced as of 2026-08-23; FY2025 results were reported 2025-12-18 before the US open. (passed 3d ago)
What Would Change Our Mind
The structure that mattered has already gone — the $43 shelf in early August, then the $36 weekly level on 2026-08-21 — so the question is no longer whether the recovery leg is intact. It is whether the shares find a floor above the May low. A weekly close below $31 would lose the 2026-05 low of $31.12 and turn the entire FY26 range into a distribution top rather than a correction inside an uptrend, at which point the 15% cc guide and the $52.05 median target would be information the market has explicitly declined to pay for twice.
Two non-price conditions would do the same work. First, target compression: Williams Trading moved to $39 on 2026-08-19, and any of Evercore ($49), Telsey ($50), Bernstein ($55), JP Morgan ($58) or the $60 pair following it below $45 would remove the valuation-gap argument that the bull case rests on. Second, the buyback: weighted average shares flat or higher than 181.4M at the December print, or year-end net leverage above the guided 1.6–1.7x, would show the repurchase pace throttled by the balance sheet.
What would rebuild the case: a weekly close back above the $39.35 area with the FY26 print confirming DTC growth near +16% cc and tariff drag contained at or below the 70bps booked in Q3. Absent that, the compressed multiple is a description of the tape, not a reason for it to turn.
Correlation Notes
- The name trades as premium consumer discretionary with a European cost base and a US revenue mix, so it carries both EUR/USD translation and US tariff policy. Q3 showed a 200bps gap between reported (+13%) and constant-currency (+15%) growth from currency alone.
- Reported results are in EUR while the listing and consensus screens are in USD, which is why the same quarter read as a 19% EPS increase (€0.74) and a one-cent miss ($0.86 vs $0.87) on 2026-08-13. Expect that split to recur every print.
- Credit and equity are linked here in an unusually direct way: the €900M 2033 notes fund the repurchase authority, so a further S&P action below BB+ would tighten the equity bid mechanically, not just sentimentally.
- Sector read-across runs through US footwear and premium wholesale channel commentary; a tariff or promotional datapoint from a peer between now and the December print is the most likely source of an unscheduled move.
Notes
- Reports in EUR while listed in USD: Q3 read as a $0.86 vs $0.87 miss even as EUR adjusted EPS grew 19% to €0.74.
- Fiscal year ends September 30 — the quarter reported 2026-08-13 covers the three months to June 30, so fiscal and calendar quarters do not align.
- S&P carries BB+ with a negative outlook (June 2026); guided net leverage of 1.6–1.7x uses the company's definition, not S&P adjusted debt/EBITDA.
- Repurchase authority of up to $500M is funded by the 19 June 2026 €900M 4.500% senior unsecured notes due 2033, so buybacks and leverage move together.
- Target dispersion is wide — UBS sat at $76 on 2026-08-04 versus a $52.05 median across 22 analysts; the median is the more informative number.
- L Catterton retains a controlling stake post-IPO; secondary offerings by the sponsor have historically been the largest supply events in the float.
Related · shared themes
MRCY
Mercury Systems Inc
Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print. Consolidation, not acceleration — the move is maturing into the report.
RXO
RXO, Inc.
Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.
ARCB
ArcBest Corporation
The twice-tested $135.76/$135.89 shelf lost on the 2026-08-24 close of $134.45, a 4.2% drop taken with the whole transport complex after Trump's 50% Canada auto/truck/parts/steel tariff post. No issuer catalyst until Q3 results ~2026-10-28; the 2026-08-28 weekly close is the first gradeable test of whether the break holds.
JBHT
J.B. Hunt Transport Services, Inc.
The $267 floor broke: the 2026-08-24 close of $259.88 is ~5.7% below the prior session, on the day Washington set Canada auto, truck and parts tariffs to 50% from 2027-01-01. The freight-recovery re-rating now has no company datapoint until an estimated 2026-10-15, with a 2026-09-20 quiet period in between, leaving the leg on third-party rate data alone.
See also · stocks to watch